Reaction Details |
| Report a problem with these data |
Target | Histone acetyltransferase KAT2B |
---|
Ligand | BDBM371564 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | PCAF AlphaLisa Binding Assay |
---|
IC50 | 94.9±n/a nM |
---|
Citation | Albrecht, BK; Burdick, DJ; Cote, A; Duplessis, M; Nasveschuk, CG; Taylor, AM Therapeutic compounds and uses thereof US Patent US10239861 Publication Date 3/26/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Histone acetyltransferase KAT2B |
---|
Name: | Histone acetyltransferase KAT2B |
Synonyms: | Histone acetyltransferase KAT2A/KAT2B | Histone acetyltransferase PCAF | KAT2B | KAT2B_HUMAN | PCAF |
Type: | PROTEIN |
Mol. Mass.: | 93045.76 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_1502838 |
Residue: | 832 |
Sequence: | MSEAGGAGPGGCGAGAGAGAGPGALPPQPAALPPAPPQGSPCAAAAGGSGACGPATAVAA
AGTAEGPGGGGSARIAVKKAQLRSAPRAKKLEKLGVYSACKAEESCKCNGWKNPNPSPTP
PRADLQQIIVSLTESCRSCSHALAAHVSHLENVSEEEMNRLLGIVLDVEYLFTCVHKEED
ADTKQVYFYLFKLLRKSILQRGKPVVEGSLEKKPPFEKPSIEQGVNNFVQYKFSHLPAKE
RQTIVELAKMFLNRINYWHLEAPSQRRLRSPNDDISGYKENYTRWLCYCNVPQFCDSLPR
YETTQVFGRTLLRSVFTVMRRQLLEQARQEKDKLPLEKRTLILTHFPKFLSMLEEEVYSQ
NSPIWDQDFLSASSRTSQLGIQTVINPPPVAGTISYNSTSSSLEQPNAGSSSPACKASSG
LEANPGEKRKMTDSHVLEEAKKPRVMGDIPMELINEVMSTITDPAAMLGPETNFLSAHSA
RDEAARLEERRGVIEFHVVGNSLNQKPNKKILMWLVGLQNVFSHQLPRMPKEYITRLVFD
PKHKTLALIKDGRVIGGICFRMFPSQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKH
DILNFLTYADEYAIGYFKKQGFSKEIKIPKTKYVGYIKDYEGATLMGCELNPRIPYTEFS
VIIKKQKEIIKKLIERKQAQIRKVYPGLSCFKDGVRQIPIESIPGIRETGWKPSGKEKSK
EPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNR
YYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLIDK
|
|
|
BDBM371564 |
---|
n/a |
---|
Name | BDBM371564 |
Synonyms: | 4-chloro-5-[[1-[[3-(difluoromethoxy)phenyl]methyl]-3-piperidyl]amino]-2-methyl-pyridazin-3-one | US10239861, Example 44 |
Type | Small organic molecule |
Emp. Form. | C18H21ClF2N4O2 |
Mol. Mass. | 398.835 |
SMILES | Cn1ncc(NC2CCCN(Cc3cccc(OC(F)F)c3)C2)c(Cl)c1=O |
Structure |
|